30
Participants
Start Date
December 17, 2019
Primary Completion Date
July 8, 2022
Study Completion Date
July 8, 2022
Darolutamide (Nubeqa, BAY1841788)
600mg, twice daily
Enzalutamide
160mg, once daily
Montefiore Medical Center, The Bronx
MidLantic Urology - Bala Cynwyd, Bala-Cynwyd
Duke University Medical Center, Durham
Carolina Urological Research Center, Myrtle Beach
Bon Secours St. Francis Hospital, Greenville
Oregon Health and Science University, Portland
New Jersey Urology, LLC, Voorhees Township
Lead Sponsor
Bayer
INDUSTRY